Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.75 USD | -2.02% | +13.08% | +51.29% |
05-13 | Janney Starts TScan Therapeutics With Buy Rating, $11 Price Target | MT |
05-13 | TScan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.29% | 510M | |
+33.13% | 49.46B | |
+1.73% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.53% | 26.61B | |
-22.68% | 18.64B | |
+8.13% | 13.16B | |
+29.18% | 12.55B | |
+24.33% | 12.1B |
- Stock Market
- Equities
- TCRX Stock
- News TScan Therapeutics, Inc.
- Sector Update: Health Care Stocks Mixed Premarket Tuesday